Citation: L. Weissbach et al., THE VALUE OF TUMOR-MARKERS IN TESTICULAR SEMINOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY, European urology, 32(1), 1997, pp. 16-22
Authors:
HARTMANN M
POTTEK T
BUSSARMAATZ R
WEISSBACH L
Citation: M. Hartmann et al., ELEVATED HUMAN CHORIONIC-GONADOTROPIN CONCENTRATIONS IN THE TESTICULAR VEIN AND IN PERIPHERAL VENOUS-BLOOD IN SEMINOMA PATIENTS - AN ANALYSIS OF VARIOUS PARAMETERS, European urology, 31(4), 1997, pp. 408-413
Citation: L. Weissbach et R. Bussarmaatz, CAN RISK-FACTORS BE DECISIVE FOR THE CHOI CE OF TREATMENT IN CLINICALSTAGE-I OF NONSEMINOMATOUS TESTICULAR-TUMORS, Aktuelle Urologie, 26(2), 1995, pp. 79-88
Citation: N. Jaeger et al., SIZE AND STATUS OF METASTASES AFTER INDUCTIVE CHEMOTHERAPY OF GERM-CELL TURNERS - INDICATION FOR SALVAGE OPERATION, World journal of urology, 12(4), 1994, pp. 196-199
Authors:
BARETTON G
DIEBOLD J
DEPASCALE T
BUSSARMAATZ R
WEISSBACH L
LOHRS U
Citation: G. Baretton et al., DEOXYRIBONUCLEIC-ACID PLOIDY IN SEMINOMAS WITH AND WITHOUT SYNCYTIOTROPHOBLASTIC CELLS, The Journal of urology, 151(1), 1994, pp. 67-71
Citation: L. Weissbach et R. Bussarmaatz, THERAPY FOR NONSEMINOMATOUS GERM-CELL TUM ORS IN CLINICAL STAGE-IIA B(PT+N1/2MO)/, Der Urologe, 32(3), 1993, pp. 183-188
Citation: R. Bussarmaatz et L. Weissbach, RETROPERITONEAL LYMPH-NODE STAGING OF TESTICULAR-TUMORS, British Journal of Urology, 72(2), 1993, pp. 234-240